tradingkey.logo
tradingkey.logo
Suchen

Conmed Corp

CNMD
Zur Watchlist hinzufügen
33.830USD
+1.070+3.27%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.02BMarktkapitalisierung
19.08KGV TTM

mehr Informationen über Conmed Corp Unternehmen

CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Conmed Corp Informationen

BörsenkürzelCNMD
Name des UnternehmensConmed Corp
IPO-datumJul 23, 1987
CEOBeyer (Patrick J)
Anzahl der mitarbeiter3900
WertpapierartOrdinary Share
GeschäftsjahresendeJul 23
Addresse11311 Concept Boulevard
StadtLARGO
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl33773
Telefon17272142974
Websitehttps://www.conmed.com/
BörsenkürzelCNMD
IPO-datumJul 23, 1987
CEOBeyer (Patrick J)

Führungskräfte von Conmed Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.04K
-8.65%
Mr. Charles (Chuck) Farkas
Mr. Charles (Chuck) Farkas
Independent Director
Independent Director
--
--
Ms. Johonna Marie Pelletier
Ms. Johonna Marie Pelletier
Treasurer and Vice President - Tax
Treasurer and Vice President - Tax
--
--
Mr. Todd W. Garner
Mr. Todd W. Garner
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.91K
+3.73%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
--
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
6.45K
+10.35%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
--
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Conmed Corp?

Die fünf größten Anteilseigner von Conmed Corp sind: Mr. David M. Bronson

Wie viele Institutionen halten Anteile an Conmed Corp (CNMD)?

Mit Stand vom 2026Q1 halten 638 Institutionen Anteile an Conmed Corp, mit einem Gesamtmarktwert von etwa 34.51M, was 114.61% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -7041128.00 gestiegen.

Was ist die größte Einnahmequelle von Conmed Corp?

Am 2026Q1 erzielte das Geschäft mit General Surgery für Conmed Corp den höchsten Umsatz in Höhe von 800.13M, was 58.20% des Gesamtumsatzes entspricht.